Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NK314

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Topoisomerase II (Topo2) inhibitors in combination with cisplatin represent a common treatment modality used for glioma patients… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2019
2019
Etoposide (VP-16) is the topoisomerase 2 (Top2) inhibitor used for treating of glioma patients however at high dose with serious… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 4
Is this relevant?
2011
2011
Adult T-cell leukemia-lymphoma (ATL) is an aggressive disease, incurable by standard chemotherapy. NK314, a new anticancer agent… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
4-Hydroxy-5-methoxy-2,3-dihydro-1H-[1,3]benzodioxolo[5,6-c]pyrrolo[1,2-f]-phenanthridium chloride (NK314) is a benzo[c… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2011
2011
1Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan; 2Department of Genetic Medicine and… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Topoisomerase II (Top2) is a ubiquitous nuclear enzyme that relieves torsional stress in chromosomal DNA during various cellular… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
NK314 is a novel synthetic benzo[c]phenanthridine alkaloid that shows strong antitumor activity. It inhibited topoisomerase II… Expand
Is this relevant?
2007
2007
NK314 is a novel synthetic benzo[c]phenanthridine alkaloid that has recently entered clinical trials as an antitumor compound… Expand
Is this relevant?
2006
2006
Proc Amer Assoc Cancer Res, Volume 47, 2006 5525 Background: NK314 is a synthetic benzo[c]phenanthridine analog and exhibits… Expand
Is this relevant?